Hester Biosciences Limited — Quarter and year ended 31 March 2026
Standalone statement of audited financial results (Amount in INR Million)
| Sr. No. | Particulars | Quarter Ended 31 March 2026 Audited (Refer note 5) |
Quarter Ended 31 December 2025 Unaudited |
Quarter Ended 31 March 2025 Audited (Refer note 5) |
Year Ended 31 March 2026 Audited |
Year Ended 31 March 2025 Audited |
|---|---|---|---|---|---|---|
| 1 | Income | |||||
| Revenue from Operations | 937.13 | 703.54 | 766.72 | 2,921.36 | 2,864.66 | |
| 2 | Other Income | 41.79 | 10.35 | 10.58 | 76.35 | 47.64 |
| Total income | 978.92 | 713.89 | 777.30 | 2,997.71 | 2,912.30 | |
| 3 | Expenses | |||||
| (a) Cost of material consumed | 165.14 | 113.12 | 90.22 | 462.23 | 388.58 | |
| (b) Purchases of stock-in-trade | 98.33 | 128.39 | 136.37 | 394.38 | 448.37 | |
| (c) Change in inventories of finished goods, traded goods and work in progress | (59.98) | (27.78) | 32.82 | (36.93) | 99.65 | |
| (d) Employee benefits expense | 139.99 | 129.14 | 121.37 | 531.74 | 547.63 | |
| (e) Finance cost | 40.94 | 8.98 | 12.49 | 71.69 | 53.67 | |
| (f) Depreciation and amortisation expense | 36.76 | 22.11 | 20.28 | 102.52 | 85.81 | |
| (g) Other expenses | 279.00 | 193.51 | 248.92 | 845.22 | 870.99 | |
| Total expenses | 700.18 | 567.47 | 662.47 | 2,370.85 | 2,494.70 | |
| 4 | Profit before exceptional items and tax | 278.74 | 146.42 | 114.83 | 626.86 | 417.60 |
| 5 | Exceptional items (Refer Note 4) | 69.96 | – | – | 69.96 | – |
| 6 | Profit before tax | 348.70 | 146.42 | 114.83 | 696.82 | 417.60 |
| 7 | Tax Expense | |||||
| Current tax | 77.23 | 24.27 | 42.09 | 144.64 | 118.08 | |
| Tax Adjustment of earlier years | 0.01 | (0.04) | (5.38) | 0.02 | (5.38) | |
| Deferred tax | 7.62 | 15.50 | (18.23) | 31.16 | (13.52) | |
| Total tax expense | 84.86 | 39.73 | 18.48 | 175.82 | 99.18 | |
| 8 | Profit after exceptional item and tax | 263.84 | 106.69 | 96.35 | 521.00 | 318.42 |
| 9 | Other Comprehensive Income | |||||
| Items that will not be reclassified to Profit or Loss | ||||||
| Remeasurement (Loss)/Gain on Defined Benefit Plans | (0.67) | 2.43 | (4.61) | (0.67) | (4.85) | |
| Income tax impact | 0.17 | (0.61) | 1.16 | 0.17 | 1.22 | |
| Total Other Comprehensive Income | (0.50) | 1.82 | (3.45) | (0.50) | (3.63) | |
| 10 | Total Comprehensive Income for the period / year | 263.34 | 108.51 | 92.90 | 520.50 | 314.79 |
| 11 | Paid-up equity share capital | – | – | – | 85.07 | 85.07 |
| 12 | Other Equity | – | – | – | 3,766.75 | 3,305.80 |
| 13 | Earnings Per Share (Face Value of INR 10 each) (Not Annualised) – Basic & Diluted (INR) | 31.01 | 12.54 | 11.33 | 61.24 | 37.43 |
Standalone assets and liabilities (Amount in INR Million)
| Particulars | As at 31 March 2026 (Audited) | As at 31 March 2025 (Audited) |
|---|---|---|
| ASSETS | ||
| Non-current assets | ||
| (a) Property, Plant & Equipment | 2,876.13 | 1,048.33 |
| (b) Capital Work-in-Progress | – | 1,766.72 |
| (c) Other Intangible Assets | 3.95 | 6.28 |
| (d) Intangible Assets under Development | 93.27 | 60.29 |
| (e) Financial Assets | ||
| (i) Investments | 642.82 | 646.89 |
| (ii) Other Financial Assets | 22.54 | 53.86 |
| (f) Other Non-current Assets | 37.11 | 25.24 |
| Total Non-current Assets | 3,675.82 | 3,607.61 |
| Current assets | ||
| (a) Inventories | 599.82 | 585.10 |
| (b) Financial Assets | ||
| (i) Trade Receivables | 920.40 | 805.95 |
| (ii) Cash and Cash Equivalents | 7.90 | 5.45 |
| (iii) Bank Balances other than (ii) above | 37.71 | 16.32 |
| (iv) Loans | 1.07 | 56.95 |
| (v) Other Financial Assets | 194.56 | 195.24 |
| (c) Other Current Assets | 136.18 | 187.34 |
| Total Current Assets | 1,897.64 | 1,852.35 |
| Total Assets | 5,573.46 | 5,459.96 |
| EQUITY AND LIABILITIES | ||
| Equity | ||
| (a) Share capital | 85.07 | 85.07 |
| (b) Other equity | 3,766.75 | 3,305.80 |
| Total Equity | 3,851.82 | 3,390.87 |
| Liabilities | ||
| Non-current liabilities | ||
| (a) Financial Liabilities | ||
| (i) Borrowings | 216.83 | 513.12 |
| (ii) Lease Liability | 2.31 | – |
| (iii) Other Financial Liabilities | 10.22 | 7.83 |
| (b) Provisions | 23.36 | 23.79 |
| (c) Deferred Tax Liabilities (Net) | 88.49 | 57.33 |
| (d) Other Non-Current Liabilities | 461.25 | 500.00 |
| Total Non-current Liabilities | 802.46 | 1,102.07 |
| Current liabilities | ||
| (a) Financial Liabilities | ||
| (i) Borrowings | 527.89 | 529.55 |
| (ii) Lease Liability | 0.52 | – |
| (iii) Trade Payables | ||
| – Total outstanding dues of micro enterprises and small enterprises | 64.00 | 98.31 |
| – Total outstanding dues of creditors other than micro enterprises and small enterprises | 141.62 | 227.02 |
| (iv) Other Financial Liabilities | 43.52 | 48.20 |
| (b) Other Current Liabilities | 79.00 | 17.22 |
| (c) Provisions | 15.29 | 9.24 |
| (d) Current Tax Liabilities | 47.34 | 37.48 |
| Total Current Liabilities | 919.18 | 967.02 |
| Total Liabilities | 1,721.64 | 2,069.09 |
| Total Equity and Liabilities | 5,573.46 | 5,459.96 |
Standalone cash flows (Amount in INR Million)
| Particulars | 31 March 2026 (Audited) | 31 March 2025 (Audited) |
|---|---|---|
| A. Cash Flow from operating activities | ||
| Profit before tax | 696.82 | 417.60 |
| Adjustments for: | ||
| Depreciation and amortisation Expense | 102.52 | 85.81 |
| Amortisation of government grant | (2.98) | – |
| Provision for doubtful debt | 31.35 | 44.12 |
| Bad debts written off | 34.96 | – |
| Loss on sale of property, plant & equipment | 2.04 | 4.86 |
| Gain on sale of investment in subsidiary | (69.96) | – |
| Net gain on assets measured at fair value through profit or loss | (17.57) | – |
| Liabilities no longer required written back (net) | – | (0.99) |
| Interest expense | 67.10 | 50.89 |
| Interest on lease liability | 0.18 | – |
| Unrealised foreign exchange gain | (9.54) | (6.11) |
| Interest income | (15.79) | (20.37) |
| Operating profit before working capital changes | 819.13 | 575.81 |
| Adjustments for: | ||
| Trade receivables | (171.21) | 13.91 |
| Inventories | (14.72) | 100.16 |
| Other assets | 49.15 | 23.19 |
| Trade payables | (119.71) | 29.38 |
| Other current liabilities | 26.01 | 2.09 |
| Provisions | 4.95 | (1.08) |
| Loans | 0.88 | (0.08) |
| Other financial liability | 22.38 | 2.34 |
| Other financial assets | 27.28 | (6.79) |
| Cash Generated from Operations | 644.14 | 738.93 |
| Income tax paid (net) | (134.94) | (99.22) |
| Net cash generated from operating activities (A) | 509.20 | 639.71 |
| B. Cash flow from investing activities | ||
| Capital expenditure on property, plant and equipment, including capital advances and capital work-in-progress and on intangible assets | (173.25) | (206.29) |
| Proceeds from sale of property, plant and equipment | 3.92 | 2.74 |
| Loans given received back | 55.00 | – |
| Interest received | 20.31 | 8.26 |
| Proceeds from sale of subsidiary | 79.60 | – |
| (Decrease)/ Increase in other bank balances | (9.19) | 4.89 |
| Net cash used in investing activities (B) | (23.61) | (190.40) |
| C. Cash flow from financing activities | ||
| Repayment of long term borrowings | (305.60) | (275.14) |
| Repayment of short-term borrowings (net) | (43.36) | (11.48) |
| Payment of principal portion of lease liabilities | (0.58) | – |
| Interest paid | (73.34) | (125.22) |
| Dividend paid | (60.26) | (51.68) |
| Net cash used in financing activities (C) | (483.14) | (463.52) |
| Net increase/(decrease) in cash and cash equivalents (A)+(B)+(C) | 2.45 | (14.21) |
| Cash and cash equivalents at the beginning of the period | 5.45 | 19.66 |
| Cash and cash equivalents at the end of the period | 7.90 | 5.45 |
Standalone segment financials (Amount in INR Million)
| Particulars | Quarter Ended 31 March 2026 (Audited) | Quarter Ended 31 December 2025 (Unaudited) | Quarter Ended 31 March 2025 (Audited) | Year Ended 31 March 2026 (Audited) | Year Ended 31 March 2025 (Audited) |
|---|---|---|---|---|---|
| Segment Revenue | |||||
| a. Poultry Healthcare | 650.72 | 513.02 | 461.35 | 2,061.31 | 1,665.83 |
| b. Animal Healthcare | 286.41 | 190.52 | 305.37 | 860.05 | 1,198.83 |
| Total Revenue from Operations | 937.13 | 703.54 | 766.72 | 2,921.36 | 2,864.66 |
| Segment Results | |||||
| a. Poultry Healthcare | 235.18 | 121.96 | 99.32 | 581.39 | 264.03 |
| b. Animal Healthcare | 102.02 | 49.27 | 56.70 | 163.85 | 254.72 |
| Total Segment Results | 337.20 | 171.23 | 156.02 | 745.24 | 518.75 |
| a. Finance Cost | 40.94 | 8.98 | 12.49 | 71.69 | 53.67 |
| b. Other unallocable expenditure (Net) | (52.44) | 15.83 | 28.70 | (23.27) | 47.48 |
| Profit before Tax | 348.70 | 146.42 | 114.83 | 696.82 | 417.60 |
| Segment Assets | |||||
| a. Poultry Healthcare | 1,229.93 | 2,643.90 | 2,522.99 | 1,229.93 | 2,522.99 |
| b. Animal Healthcare | 679.80 | 590.54 | 587.54 | 679.80 | 587.54 |
| c. Others | – | – | 2.85 | – | 2.85 |
| Unallocated Assets | 3,663.73 | 2,278.48 | 2,346.58 | 3,663.73 | 2,346.58 |
| Total | 5,573.46 | 5,512.92 | 5,459.96 | 5,573.46 | 5,459.96 |
| Segment Liabilities | |||||
| a. Poultry Healthcare | 156.69 | 199.74 | 172.32 | 156.69 | 172.32 |
| b. Animal Healthcare | 100.48 | 150.71 | 164.06 | 100.48 | 164.06 |
| Unallocated Liabilities | 1,464.47 | 1,573.99 | 1,732.71 | 1,464.47 | 1,732.71 |
| Total | 1,721.64 | 1,924.44 | 2,069.09 | 1,721.64 | 2,069.09 |
Consolidated statement of audited financial results (Amount in INR Million)
| Sr. No. | Particulars | Quarter Ended 31 March 2026 (Audited) | Quarter Ended 31 December 2025 (Unaudited) | Quarter Ended 31 March 2025 (Audited) | Year Ended 31 March 2026 (Audited) | Year Ended 31 March 2025 (Audited) |
|---|---|---|---|---|---|---|
| 1 | Income | |||||
| 1 | Revenue from Operations | 1,001.10 | 774.15 | 819.25 | 3,325.99 | 3,111.02 |
| 2 | Other Income | (30.28) | 6.69 | (69.50) | 96.84 | 39.24 |
| Total income | 970.82 | 780.84 | 749.75 | 3,422.83 | 3,150.26 | |
| 3 | Expenses | |||||
| (a) | Cost of material consumed | 212.97 | 183.40 | 155.63 | 706.22 | 639.46 |
| (b) | Purch |